Effects of spironolactone on extrasystoles and heart rate variability in haemodialysis patients: a randomised crossover trial

Effects of spironolactone on extrasystoles and heart rate variability in haemodialysis patients: a randomised crossover trial

Background: Spironolactone treatment reduces mortality in haemodialysis (HD) patients. The objective of this study was to evaluate if spironolactone affects cardiac electric activity in this population. Methods: Participants were randomised to start with spironolactone 50 mg daily or observation (12...

Full description

Bibliographic Details
Main Authors:	Michael Eklund, Olof Hellberg, Hans Furuland, Yang Cao, Erik Nilsson
Format:	Article
Language:	English
Published:	Upsala Medical Society 2021-01-01
Series:	Upsala Journal of Medical Sciences
Subjects:	haemodialysis spironolactone clinical trial long-term ecg arrhythmias heart rate variability
Online Access:	https://ujms.net/index.php/ujms/article/view/5660/13312

Similar Items

Analysis of spironolactone polymorphs in active pharmaceutical ingredients and their effect on tablet dissolution profiles
by: Renata Cunha de Resende, et al.

Spironolactone-Induced Agranulocytosis: A Case Report
by: Shu-Hwa Hsiao, et al.
Published: (2003-11-01)

Novel role of spironolactone in the therapy of resistant hypertension: Spironolactone and resistant hypertension
by: Dragojević-Simić Viktorija, et al.
Published: (2019-01-01)

Prevalence of unknown and untreated arrhythmias in an older outpatient population screened by wireless long-term recording ECG
by: Lindberg T, et al.
Published: (2016-08-01)

Evaluation of the effect of Cooled HaEmodialysis on Cognitive function in patients suffering with end-stage KidnEy Disease (E-CHECKED): feasibility randomised control trial protocol
by: Indranil Dasgupta, et al.
Published: (2020-09-01)

Spironolactone mitigates, but does not reverse, the progression of renal fibrosis in a transgenic hypertensive rat
by: Catherine J. Leader, et al.
Published: (2020-05-01)

Compatibility determination of potassium orotate with spironolactone by high-performance liquid chromatography
by: Ecaterina Mazur, et al.
Published: (2020-10-01)

Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case
by: Kapil G. Kapoor, et al.
Published: (2017-07-01)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
by: Ivan Velat, et al.
Published: (2020-08-01)

Effects of Spironolactone in Combination with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Proteinuria
by: Ha Yeon Kim, et al.
Published: (2014-12-01)

FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial
by: Alexandra Poinas, et al.
Published: (2020-06-01)

Spironolactone Reduces Aortic Stiffness in Patients With Resistant Hypertension Independent of Blood Pressure Change
by: Sudeep R. Aryal, et al.
Published: (2021-09-01)

Improving the dissolution properties of spironolactone using liquisolid technique
by: Jafar Akbari, et al.
Published: (2015-09-01)

Interactions Between Aldosterone, Spironolactone and the Cardiotonic Steroids
by: Shidyak, Amjad
Published: (2008)

An Empiric Analysis of Wavelet-Based Feature Extraction on Deep Learning and Machine Learning Algorithms for Arrhythmia Classification
by: Ritu Singh, et al.
Published: (2021-05-01)

Data-Driven ECG Denoising Techniques for Characterising Bipolar Lead Sets along the Left Arm in Wearable Long-Term Heart Rhythm Monitoring
by: Omar J. Escalona, et al.
Published: (2017-10-01)

Spironolactone to improve exercise tolerance in people with permanent atrial fibrillation and preserved ejection fraction: the IMPRESS-AF RCT
by: Eduard Shantsila, et al.
Published: (2020-07-01)

Efficacy and safety of topical spironolactone 5% cream in the treatment of acne: A pilot study
by: Azin Ayatollahi, et al.
Published: (2021-09-01)

Diuretic Effect of Prosopis farcta in Comparison with Spironolactone and Hydrochlorothiazide in Hypertensive Rats
by: Zana M.Raoof, et al.
Published: (2020-06-01)

The Effect of Spironolactone on Control of Pulmonary Hypertension in Patients with Obstructive Pulmonary Disease
by: Mohammad Emami, et al.
Published: (2019-01-01)

Caractérisation moléculaire de l’inhibition de la transcription du VIH dépendante de Tat par la spironolactone
by: Lacombe, Benoît
Published: (2016)

Development and Validation of Spectrophotometric Methods for Simultaneous Estimation of Furosemide and Spironolactone by Vierordt’s Method in Bulk and Combined Tablet Dosage Form
by: Chavan Rohankumar R., et al.
Published: (2018-07-01)

Efficacy of Spironolactone Treatment in Murine Models of Cutaneous and Visceral Leishmaniasis
by: Valter Viana Andrade-Neto, et al.
Published: (2021-04-01)

New era of dialysis: expanded haemodialysis (HDx)
by: D.D. Ivanov
Published: (2019-02-01)

HPLC – Quality by Design Approach for Simultaneous Detection of Torsemide, Spironolactone and Their Degradant Impurities
by: Bihola Unnati, et al.
Published: (2018-08-01)

More Frequent Haemodialysis Improved Outcomes: The Wish Comes True At Home
by: NxStage
Published: (2017-07-01)

Prevalence and associated factors of undiagnosed atrial fibrillation among end-stage renal disease patients on maintenance haemodialysis: a cross-sectional study
by: Izzat AlAwwa, et al.
Published: (2020-04-01)

ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE
by: V. I. Podzolkov, et al.
Published: (2017-05-01)

Coronavirus-19: Possible Therapeutic Implications of Spironolactone and Dry Extract of Glycyrrhiza glabra L. (Licorice)
by: Decio Armanini, et al.
Published: (2020-10-01)

Safety evaluation and cardiovascular effect of additional use of spironolactone in hemodialysis patients: a meta-analysis
by: Zeng Q, et al.
Published: (2019-05-01)

Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?
by: Giuseppe Remuzzi, et al.
Published: (2010-01-01)

Mineralocorticoid Receptor Antagonists Eplerenone and Spironolactone Modify Adrenal Cortex Morphology and Physiology
by: Sofia S. Pereira, et al.
Published: (2021-04-01)

Prescribing Frequent Haemodialysis in Complex Patients: Highlights from the 55th ERA–EDTA Congress
by: NxStage Medical
Published: (2018-07-01)

Quality Management System in a Haemodialysis Unit and Patient Satisfaction
by: Athanasia Kavalieratou, et al.
Published: (2021-09-01)

Rationale and design of a multi-centre randomised controlled trial of individualised cooled dialysate to prevent left ventricular systolic dysfunction in haemodialysis patients
by: Odudu Aghogho, et al.
Published: (2012-06-01)

Effects of Spironolactone and Losartan on Diabetic Nephropathy in a Type 2 Diabetic Rat Model
by: Mi Young Lee, et al.
Published: (2011-04-01)

Spironolactone-Loaded LeciPlexes as Potential Topical Delivery Systems for Female Acne: In Vitro Appraisal and Ex Vivo Skin Permeability Studies
by: Ayman Salama, et al.
Published: (2019-12-01)

Role of spironolactone in patients with resistant hypertension: A narrative review
by: Geeta Sheth, et al.
Published: (2021-01-01)

Modification of ventriculo–arterial coupling by spironolactone in nonischemic dilated cardiomyopathy
by: Mark A. Lawson, et al.
Published: (2021-04-01)

Initiating renal replacement therapy through incremental haemodialysis: Protocol for a randomized multicentre clinical trial
by: M. Fernández Lucas, et al.
Published: (2020-02-01)